The Coler Lab at Seattle Children’s Research Institute is using their expertise to support the clinical trial of an experimental coronavirus vaccine funded by National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health. The trial is being conducted at the Kaiser Permanente Washington Health Research Institute in Seattle, part of NIAID’s Infectious Diseases Clinical Research Consortium.
By UW School of Public Health
If it weren’t for a teacher who pushed her to pursue science, Rhea Coler could have slipped through the cracks as a young girl in Trinidad. Three degrees and five patents later, Coler is shaping the future of vaccine development and mentoring emerging leaders in global health.